Prognostic nutritional index as a prognostic marker in glioblastoma: Data from a cohort of 282 Italian patients

J Neurol Sci. 2019 May 15:400:175-179. doi: 10.1016/j.jns.2019.04.002. Epub 2019 Apr 3.

Abstract

Preoperative prognostic nutritional index (PNI) is linked to the clinical outcome of patients with malignant tumours, however few studies have investigated its utility in predicting outcome in glioblastoma multiforme (GBM). We performed a retrospective study on adult patients with GBM in order to evaluate the impact of PNI on overall survival (OS), after adjusting for known prognostic factor (age, extent of surgery, Karnofsky performance status, radiochemotherapy). This is an Italian, multicentre, retrospective, cohort study. The patient's cohort includes 282 individuals with a newly diagnosed GBM followed in 3 Lombardia Hospitals In all cases the diagnosis was supported by histological data. Patient's information including sex, age at onset, Karnofsky performance status (KPS), extension of surgical resection (EOR), adjuvant treatment, antiepileptic treatment, serum variables and survival data were collected. Univariate and multivariate analysis did not reveal an association between PNI and overall survival in our series of GBM patients. PNI is a controversial marker for prognosis in GBM patients and further prospective studies are necessary to elucidate its role.

Keywords: Glioblastoma multiforme; Overall survival; Prognosis; Prognostic nutritional index.

Publication types

  • Multicenter Study

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Anticonvulsants / therapeutic use
  • Brain Neoplasms / blood*
  • Brain Neoplasms / epidemiology*
  • Brain Neoplasms / therapy
  • Cohort Studies
  • Female
  • Glioblastoma / blood*
  • Glioblastoma / epidemiology*
  • Glioblastoma / therapy
  • Humans
  • Italy / epidemiology
  • Male
  • Middle Aged
  • Nutrition Assessment*
  • Prognosis
  • Retrospective Studies

Substances

  • Anticonvulsants